The gap
Stockpiles hold fixed, mostly adult strengths.
Emergency stockpiles hold finished medicines in fixed, mostly adult strengths, and the U.S. is building a reserve of raw drug ingredients that must be made into doses when needed. Children, infants and patients with kidney disease often need strengths the stockpile doesn't hold.
How the network works
Commercial work in peacetime. Countermeasures in an emergency.
The network is designed to complement national stockpiles, not replace them.
Why now
A reserve of ingredients needs a way to make doses.
PharmaTher is evaluating the approximately 26 critical drugs prioritized for the U.S. Strategic Active Pharmaceutical Ingredients Reserve, which the U.S. Administration for Strategic Preparedness and Response (ASPR) manages under a 2025 executive order. The goal is to determine which can be developed as validated digital recipes, so that stockpiled ingredients could be printed into ready-to-use doses, including for children, at qualified sites during an emergency.
Demonstration and readiness contracts
PharmaTher plans to complete a demonstration and pursue readiness contracts with U.S. and Canadian agencies, including ASPR and Defence Research and Development Canada (DRDC).
Request a capability briefing →Governments and institutions
ASPR, BARDA, DRDC, DoD/DHA, provinces, hospitals and CDMOs: talk to us about a demonstration.
Request a capability briefingBecome a node
Every CraftMake™ placement can become a node. Start on M3DICINES.
Become a National Emergency Partner ↗Node locations are illustrative. Nodes require site qualification, and readiness contracts are prospective. There is no finalized FDA framework for distributed manufacturing, and government funding and procurement are uncertain. The number of potential sites is a management estimate. Plans and timelines are forward-looking.
